Allworth Financial’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-50
| Closed | -$36 | – | 3713 |
|
|
2023
Q4 | $36 | Hold |
50
| – | – | ﹤0.01% | 3385 |
|
|
2023
Q3 | $35 | Hold |
50
| – | – | ﹤0.01% | 3379 |
|
|
2023
Q2 | $121 | Hold |
50
| – | – | ﹤0.01% | 3161 |
|
|
2023
Q1 | $410 | Buy |
+50
| New | +$664 | ﹤0.01% | 2878 |
|
|
2022
Q4 | – | Sell |
-50
| Closed | -$1K | – | 3245 |
|
|
2022
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 2583 |
|
|
2022
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 2055 |
|
|
2022
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 1849 |
|
|
2021
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 1770 |
|
|
2021
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 1635 |
|
|
2021
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 1286 |
|
|
2021
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 1261 |
|
|
2020
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 1218 |
|
|
2020
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 960 |
|
|
2020
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 1053 |
|
|
2020
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 1202 |
|
|
2019
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 946 |
|
|
2019
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 860 |
|
|
2019
Q2 | $5K | Hold |
50
| – | – | ﹤0.01% | 691 |
|
|
2019
Q1 | $7K | Hold |
50
| – | – | ﹤0.01% | 632 |
|
|
2018
Q4 | $8K | Hold |
50
| – | – | ﹤0.01% | 569 |
|
|
2018
Q3 | $12K | Hold |
50
| – | – | ﹤0.01% | 532 |
|
|
2018
Q2 | $11K | Hold |
50
| – | – | ﹤0.01% | 520 |
|
|
2018
Q1 | $12K | Hold |
50
| – | – | ﹤0.01% | 462 |
|
|
2017
Q4 | $16K | Hold |
50
| – | – | ﹤0.01% | 412 |
|
|
2017
Q3 | $18K | Hold |
50
| – | – | ﹤0.01% | 385 |
|
|
2017
Q2 | $18K | Hold |
50
| – | – | ﹤0.01% | 397 |
|
|
2017
Q1 | $15K | Hold |
50
| – | – | ﹤0.01% | 402 |
|
|
2016
Q4 | $11K | Hold |
50
| – | – | ﹤0.01% | 396 |
|
|
2016
Q3 | $12K | Hold |
50
| – | – | ﹤0.01% | 394 |
|
|
2016
Q2 | $10K | Hold |
50
| – | – | ﹤0.01% | 391 |
|
|
2016
Q1 | $22K | Hold |
50
| – | – | ﹤0.01% | 297 |
|
|
2015
Q4 | $19K | Hold |
50
| – | – | ﹤0.01% | 311 |
|
|
2015
Q3 | $14K | Hold |
50
| – | – | 0.01% | 353 |
|
|
2015
Q2 | $15K | Hold |
50
| – | – | 0.01% | 341 |
|
|
2015
Q1 | $14K | Buy |
+50
| New | +$21.6K | 0.01% | 361 |
|
Other funds holding DMK
Allworth Financial's DMK Position: Q1 2024 in Review
Allworth Financial sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 50 shares — an estimated $36 sold.
Allworth Financial first reported a position in DMK in Q1 2015 and held it in 35 quarters. The position peaked at $22K in Q1 2016. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.
- Allworth Financial reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
- Allworth Financial sold 50 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $36.
- Allworth Financial first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2015 and held it in 35 quarters.
- Allworth Financial's DMK Pharmaceuticals Corporation Common Stock position peaked at $22K in Q1 2016.
- 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.
Based on Allworth Financial's 13F filing for Q1 2024, filed 25 Apr 2024.